BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24114705)

  • 1. Serpin B5 is a CEA-interacting biomarker for colorectal cancer.
    Baek JY; Yeo HY; Chang HJ; Kim KH; Kim SY; Park JW; Park SC; Choi HS; Kim DY; Oh JH
    Int J Cancer; 2014 Apr; 134(7):1595-604. PubMed ID: 24114705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
    Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
    Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
    Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
    Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
    Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
    BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
    Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
    Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
    Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer.
    Xu Z; Wang H; Gao L; Zhang H; Wang X
    Biomed Res Int; 2019; 2019():2170830. PubMed ID: 31886181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZKSCAN3 Facilitates Liver Metastasis of Colorectal Cancer Associated with CEA-expressing Tumor.
    Kim CW; Roh SA; Tak KH; Koh BM; Ha YJ; Cho DH; Kim SY; Kim YS; Kim JC
    Anticancer Res; 2016 May; 36(5):2397-406. PubMed ID: 27127149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression Levels and Clinical Significance of Serum miR-497, CEA, CA24-2, and HBsAg in Patients with Colorectal Cancer.
    Liu Y; Chen J
    Biomed Res Int; 2022; 2022():3541403. PubMed ID: 35993056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysyl oxidase: A colorectal cancer biomarker of lung and hepatic metastasis.
    Liu Y; Wang G; Liang Z; Mei Z; Wu T; Cui A; Liu C; Cui L
    Thorac Cancer; 2018 Jul; 9(7):785-793. PubMed ID: 29766649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.